TLK-199 TLK-199: Currently TLK-199 is in Phase II of the Food and Drug Administration's (FDA's) clinical trial for the treatment of myelodsyplastic syndromes (MDS). is a small molecule drug that stimulates the bone marrow bone marrow: The soft, spongy tissue inside most bones. Blood cells are formed in the bone marrow. to produce blood cells. Currently TLK-199 is in Phase II of the Food and Drug Administration's (FDA's) clinical trial clinical trial: A type of research study that tests how a drug, medical device, or treatment approach works in people. There are several types of clinical trials. Treatment trials test new treatment options. Diagnostic trials test new ways to diagnose a disease. Screening trials test the best way to detect a… for the treatment of myelodsyplasitc syndromes (MDS).
❄️Give the Gift of Answers, Support, and Hope This Holiday Season ❄️
Please make a donation to the Aplastic Anemia Aplastic Anemia: (ay-PLASS-tik uh-NEE_mee-uh) A rare and serious condition in which the bone marrow fails to make enough blood cells - red blood cells, white blood cells, and platelets. The term aplastic is a Greek word meaning not to form. Anemia is a condition that happens when red blood cell count is low. Most… and MDS International Foundation this holiday season.
